Most Recent Articles about RDY
Dr. Reddy's Reports Positive Top-Line Data on Psoriasis Drug Jun 10, 2019 - Dr. Reddy's (RDY) reports positive top-line results from the phase IIb study on PPC-06 (formerly referred to as XP23829) in patients with moderate to severe plaque psoriasis.
BioMarin's Vimizim Wins Nod in China for Rare Genetic Malady Jun 06, 2019 - BioMarin's (BMRN) Vimizim gains an NMPA nod in China for addressing patients suffering Morquio A syndrome, an ultra-rare genetic condition.
New Strong Sell Stocks for May 22nd May 22, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Related Companies

Name Exchange Price Mkt Cap
GLPG Galapagos NV NASDAQ $115.62 $5.94B
ALKS Alkermes plc NASDAQ $38.61 $6B
CTLT Catalent, Inc. NYSE $42.57 $6.17B
UTHR United Therapeutics Corporation NASDAQ $125.98 $5.49B
LGND Ligand Pharmaceuticals Incorporated NASDAQ $253.56 $5.35B
Sector: Health Care > Industry: Major Pharmaceuticals